Catalyst Crew Technologies Corp. (OTC: CCTC) announced that its CEO, Kevin Roldan Levy, has initiated a capital structure initiative under which up to 50% of his restricted common stock holdings are expected to be canceled in exchange for a newly designated class of preferred equity. This move is intended to optimize the company's common equity base, enhance strategic flexibility, and align executive equity participation with broader corporate development goals.
Management believes that the transaction, once implemented, will contribute to a more disciplined equity framework and support the company's evolving long-term strategic initiatives, including future financing opportunities, strategic partnerships, and broader operational development. The company also expects this initiative to strengthen alignment between executive leadership and long-term corporate performance objectives while reinforcing management's commitment to disciplined growth and shareholder-oriented development.
"This initiative reflects my long-term commitment to the Company's strategic development and disciplined capital structure management," said Kevin Roldan Levy, CEO of Catalyst Crew Technologies. "As we continue advancing our broader healthcare technology strategy, I believe proactive capital structure planning will support stronger long-term positioning while reinforcing our commitment to sustainable shareholder value creation."
The company is finalizing the structure and designation of the new preferred equity and expects to provide additional updates as corporate actions are completed. Catalyst Crew continues its transition into AI-enabled healthcare, focusing on telehealth infrastructure, remote patient monitoring, and data-driven clinical insights across underserved markets. The company will evaluate further strategic initiatives to support its long-term development.
For more information, visit https://catalystcrewai.com or review SEC filings at www.sec.gov.
